Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Fernandez Henry A, Chairman & CEO. Director active across 2 companies, notably Royalty Pharma plc. Aggregated, 44 disclosures have been recorded. Split: 7 buys · 0 sell. Total volume traded: €9.3m. Activity tracked since 25 June 2021. The latest transaction was disclosed on 28 April 2026 (Don). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Fernandez Henry A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
943 shares@ US$39.76132.0% of flowClass A Ordinary SharesSEC:0001209191-23-000324:0
25 of 44 declarations
About Fernandez Henry A
Fernandez Henry A is Director and Chairman and CEO. He has 44 filings in total, and across the recent filings available, the amounts shown are buys of EUR 9,320,745 and no sells, between 2016-01-05 and 2026-04-30. The most frequent transaction nature is Attribution.